{"id":"W2097168611","doi":"10.1111/dme.12624","title":"Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes: a randomized double‐blind placebo‐controlled 102‐week trial","year":2014,"lang":"en","type":"article","venue":"Diabetic Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba","funders":"AstraZeneca","keywords":"Dapagliflozin; Medicine; Metformin; Placebo; Type 2 diabetes; Internal medicine; Regimen; Diabetes mellitus; Adverse effect; Gastroenterology; Urinary system; Urology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002961366,0.001875312,0.004600302,0.0004762752,0.0005879796,0.001304232,0.000965731,0.003014219,0.008947602],"category_scores_gemma":[0.002622788,0.001112791,0.001955698,0.0004831757,0.001117221,0.001332451,0.0004967655,0.002312267,0.001640131],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006226479,"about_ca_system_score_gemma":0.0008727895,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005863084,"about_ca_topic_score_gemma":0.00086061,"domain_scores_codex":[0.9985883,0.0006712177,0.0001428173,0.000338409,0.0001257834,0.0001333641],"domain_scores_gemma":[0.9987424,0.0003144779,0.0003460182,0.0001383446,0.00009933137,0.0003595613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9908695,0.00286455,0.0002867925,0.0002808798,0.000433236,0.00001093508,0.00001594099,0.00005560659,0.0007692004,0.00001755438,0.0002222353,0.004173584],"study_design_scores_gemma":[0.9843535,0.01440815,0.0006509713,0.00001518026,0.0002062926,0.000007223222,0.000004087555,0.00009391143,0.00009656825,0.00002659035,0.0001325354,0.000004964736],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806718,0.006443112,0.001053819,0.0008248162,0.001128482,0.005945454,0.00161119,0.0002117301,0.002109508],"genre_scores_gemma":[0.9760621,0.003259925,0.002134794,0.001562769,0.00105887,0.01113893,0.001401282,0.00003594908,0.003345302],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008947602,"threshold_uncertainty_score":0.02993274,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01651143501060446,"score_gpt":0.2660443147436545,"score_spread":0.2495328797330501,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}